首页|期刊导航|国际肝胆胰疾病杂志（英文版）|Safety and efficacy of hypofractionated radiotherapy combined with tyrosine kinase inhibitors in patients with lung metastases after liver transplantation for hepatocellular carcinoma

Safety and efficacy of hypofractionated radiotherapy combined with tyrosine kinase inhibitors in patients with lung metastases after liver transplantation for hepatocellular carcinoma

Yuan Zhuang Yi-Feng He Dan-Xue Zheng Shi-Suo Du Gen-Lai Lin Qian-Qian Zhao Zhao-Chong Zeng Yi-Xing Chen

国际肝胆胰疾病杂志（英文版）2025，Vol.24Issue(5)：484-490,7.

国际肝胆胰疾病杂志（英文版）2025，Vol.24Issue(5)：484-490,7.DOI:10.1016/j.hbpd.2025.07.003

Safety and efficacy of hypofractionated radiotherapy combined with tyrosine kinase inhibitors in patients with lung metastases after liver transplantation for hepatocellular carcinoma

Yuan Zhuang ¹Yi-Feng He ²Dan-Xue Zheng ¹Shi-Suo Du ¹Gen-Lai Lin ¹Qian-Qian Zhao ¹Zhao-Chong Zeng ¹Yi-Xing Chen¹

作者信息

1. Department of Radiation Oncology,Zhongshan Hospital,Fudan University,Shanghai 200032,China
2. Department of Liver Surgery,Zhongshan Hospital,Fudan University,Shanghai 200032,China
折叠

摘要

关键词

Hypofractionated radiotherapy/Tyrosine kinase inhibitor/Lung metastasis/Liver transplantation/Hepatocellular carcinoma

Key words

Hypofractionated radiotherapy/Tyrosine kinase inhibitor/Lung metastasis/Liver transplantation/Hepatocellular carcinoma

引用本文复制引用

Yuan Zhuang,Yi-Feng He,Dan-Xue Zheng,Shi-Suo Du,Gen-Lai Lin,Qian-Qian Zhao,Zhao-Chong Zeng,Yi-Xing Chen..Safety and efficacy of hypofractionated radiotherapy combined with tyrosine kinase inhibitors in patients with lung metastases after liver transplantation for hepatocellular carcinoma[J].国际肝胆胰疾病杂志（英文版）,2025,24(5):484-490,7.

基金项目

This study was supported by grants from the National Natu-ral Science Foundation of China(82102913 and 82102823)and the Special Clinical Research Program of the Health Industry,Shanghai Municipal Health Commission(202340179). （82102913 and 82102823）

国际肝胆胰疾病杂志（英文版）

ISSN：1499-3872

访问量0

下载量0

段落导航